John M Watkins

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer
    John M Watkins
    MUSC, 169 Ashley Avenue, Charleston, SC 29425, USA
    J S C Med Assoc 104:36-9. 2008
  2. ncbi Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Head Neck 31:493-502. 2009
  3. ncbi Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    J Med Imaging Radiat Oncol 54:483-9. 2010
  4. ncbi Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Jpn J Clin Oncol 41:334-42. 2011
  5. ncbi Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer
    Bree N Ruppert
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
    Am J Clin Oncol 33:346-52. 2010
  6. ncbi Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Jpn J Radiol 28:340-8. 2010
  7. ncbi Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29414, USA
    Laryngoscope 120:236-42. 2010
  8. ncbi Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy
    Jennifer L Harper
    Department of Radiation Oncology, Medical University of South Carolina, Hollings Cancer Center, 169 Ashley Ave MSC 318 Charleston, SC 29425, USA
    Am J Surg 199:204-9. 2010
  9. ncbi Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups
    A Jason Zauls
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Int J Radiat Oncol Biol Phys 82:21-9. 2012
  10. ncbi Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Int J Radiat Oncol Biol Phys 74:1108-13. 2009

Collaborators

Detail Information

Publications17

  1. ncbi Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer
    John M Watkins
    MUSC, 169 Ashley Avenue, Charleston, SC 29425, USA
    J S C Med Assoc 104:36-9. 2008
  2. ncbi Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Head Neck 31:493-502. 2009
    ..Reirradiation of locoregionally recurrent, previously irradiated head/neck cancer may be considered in situations of unresectability, medical inoperability, or adverse pathologic features found at salvage resection...
  3. ncbi Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    J Med Imaging Radiat Oncol 54:483-9. 2010
    ..The present investigation describes patterns of failure, disease control, and survival outcomes for involved-field radiotherapy with concurrent chemotherapy, without elective irradiation of uninvolved mediastinal nodal regions...
  4. ncbi Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Jpn J Clin Oncol 41:334-42. 2011
    ..Cisplatin-based chemoradiotherapy is standard treatment for locally advanced esophageal and gastroesophageal cancers; however, the optimal chemotherapy regimen remains to be defined...
  5. ncbi Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer
    Bree N Ruppert
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA
    Am J Clin Oncol 33:346-52. 2010
    ..To compare toxicities, disease control, and survival outcomes for patients treated with either cisplatin/irinotecan versus carboplatin/paclitaxel concurrent chemoradiotherapy for locally advanced esophageal cancer...
  6. ncbi Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Jpn J Radiol 28:340-8. 2010
    ....
  7. ncbi Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29414, USA
    Laryngoscope 120:236-42. 2010
    ..The present investigation reports toxicities, disease control, patterns of failure, and survival outcomes in a large mature cohort of patients treated with low-dose weekly platinum-based concurrent chemoradiotherapy...
  8. ncbi Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy
    Jennifer L Harper
    Department of Radiation Oncology, Medical University of South Carolina, Hollings Cancer Center, 169 Ashley Ave MSC 318 Charleston, SC 29425, USA
    Am J Surg 199:204-9. 2010
    ....
  9. ncbi Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups
    A Jason Zauls
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Int J Radiat Oncol Biol Phys 82:21-9. 2012
    ..The objective of this study was to compare oncologic outcomes in women treated with MammoSite brachytherapy (MB) vs. whole breast irradiation (WBI) after stratification into Statement groups...
  10. ncbi Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Int J Radiat Oncol Biol Phys 74:1108-13. 2009
    ..To describe incidence and identify factors associated with development of severe acute esophagitis during hyperfractionated radiotherapy with concurrent chemotherapy (BID-CRT) in patients with limited-stage small-cell lung cancer (SCLC)...
  11. ncbi Effect of body mass index on chemoradiation outcomes in head and neck cancer
    Theodore R McRackan
    Department of Otolaryngology Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina 29725, USA
    Laryngoscope 118:1180-5. 2008
    ..To investigate the association between initial body mass index (BMI) and chemoradiation therapy (CRT) outcomes in head and neck cancer patients...
  12. ncbi Imaging applications in multicatheter brachytherapy for soft tissue sarcomas
    Jennifer L Harper
    Medical University of South Carolina, Charleston, SC 29425, USA
    Cancer Imaging 10:127-34. 2010
    ..In the postoperative setting, imaging is utilized to assess the accuracy of target volume coverage and integrity of the implant, as well as in three-dimensional treatment planning...
  13. ncbi High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    J Neurooncol 93:343-8. 2009
    ..To describe outcomes associated with high-dose radiotherapy with and without temozolomide for high grade central nervous system (CNS) neoplasms...
  14. ncbi Helical tomotherapy for total lymphoid irradiation
    Kathryn W McCutchen
    Department of Radiation Oncology, Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29425, USA
    Radiat Med 26:622-6. 2008
    ..Treatment planning allowed dose minimization to the spinal cord, kidneys, intestinal compartment, and lungs. The patient tolerated treatment well without acute adverse effects, and he is now in early follow-up...
  15. ncbi The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma
    Emma C Batchelor
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Eur J Obstet Gynecol Reprod Biol 141:163-8. 2008
    ....
  16. ncbi Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Brachytherapy 7:305-9. 2008
    ..Describe the incidence and identify risk factors for seroma development after MammoSite breast brachytherapy (MBT)...
  17. ncbi A case of orbital Rosai-Dorfman disease responding to radiotherapy
    Samuel Lewis Cooper
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC, USA
    J Pediatr Hematol Oncol 30:744-8. 2008
    ..We present a case of salvage radiotherapy for progressive orbital RDD refractory to surgery and chemotherapy in a pediatric patient...